OpenBilldrug price receipt

NADAC week of 2026-10-14

AMLODIPINE-VALSARTAN 5-160 MG

For 30 tablets

Pharmacies pay

$7.92 filed

30 × $0.26403 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$20.96 filed

30 × $0.69858 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

2.6× estimated

Medicare paid 2.6× what pharmacies pay.

Part D averages every strength and form sold under “Amlodipine-Valsartan” / “Amlodipine Besylate/Valsartan” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$14.11 estimated

$7.92 + $1.19 (15%) + $5.00 fee per fill = $14.11

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

AMLODIPINE-VALSARTAN 5-160 MG is how the CMS NADAC file names this product. The FDA NDC Directory lists it as amlodipine and valsartan.

FDA gives its dosage form as “tablet, film coated” and “tablet” and its route as oral.

FDA lists 5 labelers (the companies named on the label) for its NDCs, among them Mylan Pharmaceuticals Inc., Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. and Macleods Pharmaceuticals Limited.

FDA lists it under 3 Established Pharmacologic Classes: Angiotensin 2 Receptor Blocker, Calcium Channel Blocker and Dihydropyridine Calcium Channel Blocker.

The NADAC file of 2026-10-14 prices it under 8 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $7.92 for 30 tablets (30 × $0.26403 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 5 labelers

LabelerNDCsPharmacies pay per unit
Alembic Pharmaceuticals Inc.2$0.26403 per EA filed
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.2$0.26403 per EA filed
Macleods Pharmaceuticals Limited2$0.26403 per EA filed
Aurobindo Pharma Limited1$0.26403 per EA filed
Mylan Pharmaceuticals Inc.1$0.26403 per EA filed
All 8 NDCs, with labeler and price
  • 00378-1721-93 · Mylan Pharmaceuticals Inc. · $0.26403 per EA · eff. 2026-09-23 filed
  • 23155-0844-03 · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. · $0.26403 per EA · eff. 2026-09-23 filed
  • 23155-0844-09 · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. · $0.26403 per EA · eff. 2026-09-23 filed
  • 33342-0279-07 · Macleods Pharmaceuticals Limited · $0.26403 per EA · eff. 2026-09-23 filed
  • 33342-0279-10 · Macleods Pharmaceuticals Limited · $0.26403 per EA · eff. 2026-09-23 filed
  • 62332-0205-30 · Alembic Pharmaceuticals Inc. · $0.26403 per EA · eff. 2026-09-23 filed
  • 62332-0205-90 · Alembic Pharmaceuticals Inc. · $0.26403 per EA · eff. 2026-09-23 filed
  • 65862-0737-30 · Aurobindo Pharma Limited · $0.26403 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

3 other products in the NADAC file share the FDA nonproprietary name amlodipine and valsartan with AMLODIPINE-VALSARTAN 5-160 MG.

ProductPharmacies pay per unitMedicare per unit
AMLODIPINE-VALSARTAN 5-160 MG this page
generic · tablet, film coated / tablet
$0.26403 per EA filed
eff. 2026-09-23
$0.69858 per EA filed
Part D 2024 average
AMLODIPINE-VALSARTAN 5-320 MG
generic · tablet, film coated / tablet
$0.3511 per EA filed
eff. 2026-09-23
$0.69858 per EA filed
Part D 2024 average
AMLODIPINE-VALSARTAN 10-160 MG
generic · tablet, film coated / tablet
$0.32969 per EA filed
eff. 2026-09-23
$0.69858 per EA filed
Part D 2024 average
AMLODIPINE-VALSARTAN 10-320 MG
generic · tablet, film coated / tablet
$0.43177 per EA filed
eff. 2026-09-23
$0.69858 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 8 NDCs’ NADAC prices is $0.26403 per EA filed.

Of the 107 other products in FDA’s Angiotensin 2 Receptor Blocker class priced per EA, 76 have a higher middle NADAC price and 31 a lower one. The one in the middle is OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5, at $1.15137 per EA filed (eff. 2026-09-23).

Of the 107 other products in FDA’s Calcium Channel Blocker class priced per EA, 76 have a higher middle NADAC price and 31 a lower one. The one in the middle is DILTIAZEM 24H ER(LA) 240 MG TB, at $1.0087 per EA filed (eff. 2026-09-23).

Of the 67 other products in FDA’s Dihydropyridine Calcium Channel Blocker class priced per EA, 50 have a higher middle NADAC price and 17 a lower one. The one in the middle is ISRADIPINE 2.5 MG CAPSULE, at $1.13676 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $20.96 for 30 tablets, at an average of $0.69858 per EA in 2024 (2024-01-01 to 2024-12-31) for “Amlodipine-Valsartan” and “Amlodipine Besylate/Valsartan”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 437,348 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for AMLODIPINE-VALSARTAN 5-160 MG labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Amlodipine-Valsartan / Amlodipine Besylate/Valsartan: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.